首页 > 最新文献

International Blood Research & Reviews最新文献

英文 中文
Determining the Genotype of the RH Blood Group System in Maltese Blood Donors 确定马耳他献血者RH血型系统的基因型
Pub Date : 2023-10-11 DOI: 10.9734/ibrr/2023/v14i4325
Antonella Giordmaina Powney, Joseph Borg, Jesmond Debono
Aims: The Rh blood group system is a complex protein based system having the D, C, c, E and e as the most immunogenic antigens. This blood group system has a vital role in transfusion medicine thus by DNA typing, important medical issues in transfusion practice can be resolved when serological techniques fail. The aim of the study was to determine the frequency of the RH genotype in the Maltese blood donors using molecular techniques. Methodology: 797 blood donor samples were enrolled in this study. An allele-specific polymerase chain reaction (AS-PCR) method was used to determine the presence of RHD, RHCE*E and RHCE*e, while multiplex PCR was used to test for RHCE*C/c. Results: Out of 797 samples studied, the most common allele was RHCE*e with a percentage of 98. The most common genotype in RhD positive samples was DCcee and in RhD negative samples, the most common was dccee. The most frequent haplotype was DCe. Conclusion: Like in previous studies, this research also concludes that the distribution of the RH genotype varies in different geographical areas. Further studies working with larger sample size and better techniques would share better light on the molecular function of these loci.
目的:Rh血型系统是一个以D、C、C、E、E为最具免疫原性抗原的复杂蛋白质系统。这种血型系统在输血医学中起着至关重要的作用,因此通过DNA分型,当血清学技术失败时,输血实践中的重要医学问题可以得到解决。该研究的目的是利用分子技术确定马耳他献血者RH基因型的频率。方法:本研究共纳入797份献血者样本。采用等位基因特异性聚合酶链反应(AS-PCR)检测RHD、RHCE*E和RHCE*E是否存在,采用多重PCR检测RHCE*C/ C是否存在。& # x0D;结果:在所研究的797个样本中,最常见的等位基因是RHCE*e,占98%。RhD阳性样本中最常见的基因型为DCcee, RhD阴性样本中最常见的基因型为DCcee。最常见的单倍型是DCe。 结论:与以往的研究一样,本研究也得出RH基因型在不同地理区域的分布存在差异的结论。通过更大的样本量和更好的技术,进一步的研究将更好地揭示这些基因座的分子功能。
{"title":"Determining the Genotype of the RH Blood Group System in Maltese Blood Donors","authors":"Antonella Giordmaina Powney, Joseph Borg, Jesmond Debono","doi":"10.9734/ibrr/2023/v14i4325","DOIUrl":"https://doi.org/10.9734/ibrr/2023/v14i4325","url":null,"abstract":"Aims: The Rh blood group system is a complex protein based system having the D, C, c, E and e as the most immunogenic antigens. This blood group system has a vital role in transfusion medicine thus by DNA typing, important medical issues in transfusion practice can be resolved when serological techniques fail. The aim of the study was to determine the frequency of the RH genotype in the Maltese blood donors using molecular techniques.
 Methodology: 797 blood donor samples were enrolled in this study. An allele-specific polymerase chain reaction (AS-PCR) method was used to determine the presence of RHD, RHCE*E and RHCE*e, while multiplex PCR was used to test for RHCE*C/c. 
 Results: Out of 797 samples studied, the most common allele was RHCE*e with a percentage of 98. The most common genotype in RhD positive samples was DCcee and in RhD negative samples, the most common was dccee. The most frequent haplotype was DCe.
 Conclusion: Like in previous studies, this research also concludes that the distribution of the RH genotype varies in different geographical areas. Further studies working with larger sample size and better techniques would share better light on the molecular function of these loci.","PeriodicalId":13659,"journal":{"name":"International Blood Research & Reviews","volume":"17 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136211454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Systematic Review of Genetic-Related Risk Factor and Inhibitor Epidemiology in People with Severe Hemophilia a from Africa: A 2023 Update 非洲a型严重血友病患者遗传相关危险因素和抑制剂流行病学的系统评价:2023年最新进展
Pub Date : 2023-10-09 DOI: 10.9734/ibrr/2023/v14i4324
Tatiana Baglo, Alban Zohoun, Simon Azonbakin, Bienvenu Houssou, Romaric Massi, Charlotte Orou Guiwa, Ludovic Anani, Dorothée Kindé Gazard, Awa Omar Touré Fall
Background and Aims: Prevalence of factor VIII inhibitors in patients with hemophilia A varies from study to study, ranging from 15% to 30%. The important risk of inhibitor development is factor VIII mutation responsible for hemophilia A. Few studies have reported factor VIII mutations in Africa. The aim of this study was to review on FVIII gène mutations of severe hemophilia A in Africa and those associated with inhibitor development. Study Design and Methodology: A systematic review was carried out using the electronic databases Pubmed, Science Direct, Index Medicus Global and African Journals online and the key words "hemophilia A", "inhibitor", "genetic" and "Africa". Studies written in French or English on the African continent and published between 2012 and 2023 were included. Publications relating to acquired hemophilia and duplicates were excluded. In the end, 17 articles were selected. Results: The factor VIII mutations involved in severe hemophilia A in Africa are variable, consisting of intron 22 inversion, large or point deletions, nonsense and missense mutations and splicing abnormalities. Among the latter, numerous previously unrecorded mutations have been identified, and a single case of intron 1 inversion has been found in Algeria. Prevalence of factor VIII inhibitors in severe hemophilia A in Africa varies between 7,8% and 30%. Genetic abnormalities associated with inhibitors include intron 22 inversion, large deletions such as exon 1-13 deletion, nonsense mutations and c.1010-2A>G mutation. Conclusion: A better knowledge of the factor VIII mutations involved in severe hemophilia A in Africa will help improve patient management.
背景和目的:血友病A患者中因子VIII抑制剂的患病率因研究而异,从15%到30%不等。抑制剂发展的重要风险是导致a型血友病的因子VIII突变,很少有研究报道非洲的因子VIII突变。本研究的目的是回顾非洲严重血友病A的FVIII基因突变以及与抑制剂发展相关的突变。研究设计与方法:采用Pubmed、Science Direct、Index Medicus Global和African Journals online电子数据库,以“血友病A”、“抑制剂”、“遗传”和“非洲”为关键词进行系统综述。其中包括2012年至2023年期间在非洲大陆用法语或英语撰写的研究报告。排除了与获得性血友病相关的出版物和重复出版物。最终,17篇文章入选。 结果:非洲地区严重A型血友病患者的因子VIII突变是可变的,包括内含子22倒置、大或点缺失、无义和错义突变以及剪接异常。在后者中,已经发现了许多以前未记录的突变,并且在阿尔及利亚发现了一个内含子1反转的病例。非洲严重A型血友病患者中因子VIII抑制剂的患病率在7.8%至30%之间。与抑制剂相关的遗传异常包括内含子22反转、大缺失(如外显子1-13缺失)、无义突变和c.1010-2A>G突变。结论:更好地了解与非洲严重血友病A相关的因子VIII突变将有助于改善患者管理。
{"title":"Systematic Review of Genetic-Related Risk Factor and Inhibitor Epidemiology in People with Severe Hemophilia a from Africa: A 2023 Update","authors":"Tatiana Baglo, Alban Zohoun, Simon Azonbakin, Bienvenu Houssou, Romaric Massi, Charlotte Orou Guiwa, Ludovic Anani, Dorothée Kindé Gazard, Awa Omar Touré Fall","doi":"10.9734/ibrr/2023/v14i4324","DOIUrl":"https://doi.org/10.9734/ibrr/2023/v14i4324","url":null,"abstract":"Background and Aims: Prevalence of factor VIII inhibitors in patients with hemophilia A varies from study to study, ranging from 15% to 30%. The important risk of inhibitor development is factor VIII mutation responsible for hemophilia A. Few studies have reported factor VIII mutations in Africa. The aim of this study was to review on FVIII gène mutations of severe hemophilia A in Africa and those associated with inhibitor development.
 Study Design and Methodology: A systematic review was carried out using the electronic databases Pubmed, Science Direct, Index Medicus Global and African Journals online and the key words \"hemophilia A\", \"inhibitor\", \"genetic\" and \"Africa\". Studies written in French or English on the African continent and published between 2012 and 2023 were included. Publications relating to acquired hemophilia and duplicates were excluded. In the end, 17 articles were selected.
 Results: The factor VIII mutations involved in severe hemophilia A in Africa are variable, consisting of intron 22 inversion, large or point deletions, nonsense and missense mutations and splicing abnormalities. Among the latter, numerous previously unrecorded mutations have been identified, and a single case of intron 1 inversion has been found in Algeria. Prevalence of factor VIII inhibitors in severe hemophilia A in Africa varies between 7,8% and 30%. Genetic abnormalities associated with inhibitors include intron 22 inversion, large deletions such as exon 1-13 deletion, nonsense mutations and c.1010-2A>G mutation.
 Conclusion: A better knowledge of the factor VIII mutations involved in severe hemophilia A in Africa will help improve patient management.","PeriodicalId":13659,"journal":{"name":"International Blood Research & Reviews","volume":"26 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135142092","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Blood Transfusion Request and Utilization: The Trend in a Tertiary Health Care Centre in North Central Nigeria 输血请求和使用:尼日利亚中北部三级保健中心的趋势
Pub Date : 2023-10-05 DOI: 10.9734/ibrr/2023/v14i4323
None Jatau E. D., None Ma’an V. T., None Ofakunrin A. O. D., None Ntuhun B. D., None Damulak O. D.
Background: An effective blood transfusion service is anchored on an adequate supply of safe blood and its components as well as its accessibility and appropriate clinical use. There is a contrast in blood supplies and utilization between the high, middle and low-income countries necessitating the formulation of appropriate modalities to ensure judicious use of blood while minimizing wastage. Aims: This study was aimed at assessing the blood transfusion request trend in our institution and its utilization with the intent of curtailing the wastage of safe blood for transfusion. Study Design: It is a retrospective study. Place and Duration of Study: Jos University Teaching Hospital Blood Bank from January 2022 to December 2022. Methodology: Appropriately filled blood transfusion request forms of the Jos University Teaching Hospital compared with the blood bank In-house records from January 2022 to December 2022 were reviewed. Request dates, requesting Department, Unit or Specialty, indications for request, Number of units requested, and number eventually utilized were used to determine blood transfusion indices which are indicative of efficient and significant blood use. Results: Eight thousand, five hundred forty-eight (8,548) blood transfusion request forms from the blood bank and patients' folders were reviewed and compared with the Blood Bank's in-house records. Requests for blood transfusion for over 460 indications were received from twenty-six (26) departments and units. There was a general Crossmatch: Transfusion ratio (C: T) of 1.7 with a transfusion index (TI) of 1.2 and transfusion probability (TP) of 48.0%. Conclusion: Transfusion requests were characterized by low utilization across departments and units. This calls for the establishment of a transfusion protocol for the determination of blood volume required for every indication so that this limited commodity will be made available and accessible when needed.
背景:有效的输血服务以安全血液及其成分的充足供应以及可及性和适当的临床使用为基础。高、中、低收入国家在血液供应和利用方面存在差异,因此有必要制定适当的模式,以确保明智地使用血液,同时尽量减少浪费。目的:本研究旨在了解我院输血需求趋势及使用情况,以减少安全输血用血的浪费。研究设计:回顾性研究。 学习地点和时间:Jos大学教学医院血库,2022年1月至2022年12月。 方法:将乔斯大学教学医院正确填写的输血申请单与血库2022年1月至2022年12月的内部记录进行比较。使用请求日期、请求科室、单位或专科、请求适应症、请求单位数和最终使用的数量来确定指示有效和显著用血的输血指标。 结果:共审查血库及患者病历8,548份输血申请单,并与血库内部记录进行比较。从26个科室和单位收到460多个指征的输血请求。总体交叉匹配:输血比(C: T)为1.7,输血指数(TI)为1.2,输血概率(TP)为48.0%。 结论:各科室、各单位输血请求使用率低。这就要求制定一项输血方案,以确定每一种指征所需的血容量,以便在需要时提供和获得这种有限的商品。
{"title":"Blood Transfusion Request and Utilization: The Trend in a Tertiary Health Care Centre in North Central Nigeria","authors":"None Jatau E. D., None Ma’an V. T., None Ofakunrin A. O. D., None Ntuhun B. D., None Damulak O. D.","doi":"10.9734/ibrr/2023/v14i4323","DOIUrl":"https://doi.org/10.9734/ibrr/2023/v14i4323","url":null,"abstract":"Background: An effective blood transfusion service is anchored on an adequate supply of safe blood and its components as well as its accessibility and appropriate clinical use. There is a contrast in blood supplies and utilization between the high, middle and low-income countries necessitating the formulation of appropriate modalities to ensure judicious use of blood while minimizing wastage.
 Aims: This study was aimed at assessing the blood transfusion request trend in our institution and its utilization with the intent of curtailing the wastage of safe blood for transfusion.
 Study Design: It is a retrospective study.
 Place and Duration of Study: Jos University Teaching Hospital Blood Bank from January 2022 to December 2022.
 Methodology: Appropriately filled blood transfusion request forms of the Jos University Teaching Hospital compared with the blood bank In-house records from January 2022 to December 2022 were reviewed. Request dates, requesting Department, Unit or Specialty, indications for request, Number of units requested, and number eventually utilized were used to determine blood transfusion indices which are indicative of efficient and significant blood use.
 Results: Eight thousand, five hundred forty-eight (8,548) blood transfusion request forms from the blood bank and patients' folders were reviewed and compared with the Blood Bank's in-house records. Requests for blood transfusion for over 460 indications were received from twenty-six (26) departments and units. There was a general Crossmatch: Transfusion ratio (C: T) of 1.7 with a transfusion index (TI) of 1.2 and transfusion probability (TP) of 48.0%.
 Conclusion: Transfusion requests were characterized by low utilization across departments and units. This calls for the establishment of a transfusion protocol for the determination of blood volume required for every indication so that this limited commodity will be made available and accessible when needed.","PeriodicalId":13659,"journal":{"name":"International Blood Research & Reviews","volume":"440 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134977171","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interaction of Red Cell Indices and Blood Group in Diabetic Patients above 50 Years of Age 50岁以上糖尿病患者红细胞指标与血型的相互作用
Pub Date : 2023-09-29 DOI: 10.9734/ibrr/2023/v14i4322
None Moore-Igwe Beatrice W., None Ken-Ezihuo Stella U., Baribefe Banavule Daniel Koate
Introduction: A group of metabolic diseases with a hyperglycemic phenotype known as diabetes mellitus impact both industrialized and developing nations. It is brought on by deviations in insulin synthesis, action, or both. Research Objective: This study seeks to associate the interaction of red cell indices and blood group in diabetic patients above 50 years of age. This is a case control study in which a convenient sample size of 100 individuals were recruited from a consenting population at a private hospital in Port Harcourt, Rivers State, 50 of whom were diabetic, and the remaining 50 were not. Methods: Using the automated 3-part differential hematology analyzer Sysmex KX-21N, a Full blood count (FBC) and differential was obtained using (Sysmex Corporation Kobe, Japan) Standardization, instrument calibration, and analysis of sample was achieved in line with accordance with the manufacturer's manual to determine the red cell indices and grouping of cells using the tile approach to determine the ABO Blood Groups. Blood samples were taken from the veins using a vacutainer tube and needle according to Chesbrough's instructions, and then put in EDTA anticoagulated bottles with clear labelling. These samples were transported right away using the triple packing procedure to the lab and stored until testing at 4°C. Inferential statistics utilizing the students' statistical t-test were employed to compare the results. Results: Blood group O, with a total of 25 (50%), had the highest prevalence of diabetes mellitus, followed by blood group A with a total of 12 subjects (24%) and blood group B with a total of 8 subjects (16%) and blood group AB came in last with a total of 5 participants (10%), respectively. In this study, blood group O predominated over blood groups A and B (47% against 25% versus 17%, respectively). The least common blood type in this study was AB (11%). When the Packed Cell Volume, Haemoglobin, Red Blood Cell, Mean Cell volume, Mean Cell Haemoglobin, Mean Cell Haemoglobin Concentration, and Red cell Distribution Width were examined between diabetic and non-diabetic participants, no statistically significant (p<0.05) difference was found. Conclusion: The findings of this study suggest that blood types O and AB are more prevalent in diabetics. We can deduce that a person's blood type may be a risk factor for developing this condition and may be useful in diagnosing it.
一组代谢疾病与高血糖表型被称为糖尿病影响工业化和发展中国家。它是由胰岛素合成、作用或两者的偏差引起的。研究目的:探讨50岁以上糖尿病患者红细胞指标与血型的相互作用。这是一项病例对照研究,从河州哈科特港一家私立医院的同意人群中招募了100人作为方便的样本量,其中50人患有糖尿病,其余50人不是。方法:采用Sysmex KX-21N全自动三组分差血液学分析仪,采用(Sysmex Corporation Kobe, Japan)进行全血细胞计数(FBC)和差血液学测定,标准化、仪器校准,按照生产厂家说明书对样品进行分析,测定红细胞指标,采用tile法对细胞进行分组测定ABO血型。根据Chesbrough的说明,使用真空抽管和针头从静脉中抽取血液样本,然后放入EDTA抗凝瓶中,并有明确的标签。这些样品使用三重包装程序立即运输到实验室,并保存直到在4°C下进行测试。利用学生统计t检验进行推理统计,比较结果。 结果:O型血糖尿病患病率最高,25人(50%),其次是a型血,12人(24%),其次是B型血,8人(16%),最后是AB型血,5人(10%)。在本研究中,O型血高于A型和B型血(分别为47%对25%和17%)。在这项研究中最不常见的血型是AB型(11%)。当检查堆积细胞体积、血红蛋白、红细胞、平均细胞体积、平均细胞血红蛋白、平均细胞血红蛋白浓度和红细胞分布宽度时,没有发现糖尿病和非糖尿病参与者之间的统计学差异(p<0.05)。 结论:本研究结果提示,O型血和AB型血在糖尿病患者中更为普遍。我们可以推断,一个人的血型可能是患这种疾病的一个危险因素,可能对诊断有用。
{"title":"Interaction of Red Cell Indices and Blood Group in Diabetic Patients above 50 Years of Age","authors":"None Moore-Igwe Beatrice W., None Ken-Ezihuo Stella U., Baribefe Banavule Daniel Koate","doi":"10.9734/ibrr/2023/v14i4322","DOIUrl":"https://doi.org/10.9734/ibrr/2023/v14i4322","url":null,"abstract":"Introduction: A group of metabolic diseases with a hyperglycemic phenotype known as diabetes mellitus impact both industrialized and developing nations. It is brought on by deviations in insulin synthesis, action, or both.&#x0D; Research Objective: This study seeks to associate the interaction of red cell indices and blood group in diabetic patients above 50 years of age. This is a case control study in which a convenient sample size of 100 individuals were recruited from a consenting population at a private hospital in Port Harcourt, Rivers State, 50 of whom were diabetic, and the remaining 50 were not.&#x0D; Methods: Using the automated 3-part differential hematology analyzer Sysmex KX-21N, a Full blood count (FBC) and differential was obtained using (Sysmex Corporation Kobe, Japan) Standardization, instrument calibration, and analysis of sample was achieved in line with accordance with the manufacturer's manual to determine the red cell indices and grouping of cells using the tile approach to determine the ABO Blood Groups. Blood samples were taken from the veins using a vacutainer tube and needle according to Chesbrough's instructions, and then put in EDTA anticoagulated bottles with clear labelling. These samples were transported right away using the triple packing procedure to the lab and stored until testing at 4°C. Inferential statistics utilizing the students' statistical t-test were employed to compare the results.&#x0D; Results: Blood group O, with a total of 25 (50%), had the highest prevalence of diabetes mellitus, followed by blood group A with a total of 12 subjects (24%) and blood group B with a total of 8 subjects (16%) and blood group AB came in last with a total of 5 participants (10%), respectively. In this study, blood group O predominated over blood groups A and B (47% against 25% versus 17%, respectively). The least common blood type in this study was AB (11%). When the Packed Cell Volume, Haemoglobin, Red Blood Cell, Mean Cell volume, Mean Cell Haemoglobin, Mean Cell Haemoglobin Concentration, and Red cell Distribution Width were examined between diabetic and non-diabetic participants, no statistically significant (p<0.05) difference was found.&#x0D; Conclusion: The findings of this study suggest that blood types O and AB are more prevalent in diabetics. We can deduce that a person's blood type may be a risk factor for developing this condition and may be useful in diagnosing it.","PeriodicalId":13659,"journal":{"name":"International Blood Research & Reviews","volume":"77 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135199773","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Distribution of Severe Acute Respiratory Syndrome Corona Virus-2 (SARS-CoV-2) Immunoglobulins G and M among Frontline Health Workers in Eleme Local Government of Rivers State, Nigeria 尼日利亚河流州Eleme地方政府一线卫生工作者中严重急性呼吸综合征冠状病毒-2 (SARS-CoV-2)免疫球蛋白G和M的分布
Pub Date : 2023-09-14 DOI: 10.9734/ibrr/2023/v14i4320
Sotonye L. Gillis-Harry, Beauty E. Echonwere-Uwikor, Evelyn M. Eze
Background: The fight against Corona Virus Disease (COVID-19) globally among front line health workers has been a challenging task, it encompasses working lengthy hours at the isolation Centre’s, intensive care units, emergency departments and molecular laboratories, and also been exposed to pathogens, fatigue, and psychological distress. This has led to high morbidity and mortality rate among front line health workers all over the globe. Aim: This study aimed at determining the distribution of SARS CoV -2 IgG and IgM among frontline health workers in Eleme Local Government of Rivers State, Nigeria. Materials and Methods: A total of 100 frontline Covid-19 health workers were recruited for this study comprising 48 males and 52 females with ages between 23 and 49 years and included janitors, hygienist, nurses, data Officers, logistics and ambulance drivers, physicians, and medical laboratory scientists, working at the molecular laboratories, sample collection booths and isolation center. The bio-data of the subjects were obtained using a well-structured questionnaire. Only subjects who gave informed consent were recruited for this study. 60ul of capillary blood was collected from each participant using an aseptic technique and immediately followed by the analysis of SAR-CoV-2 IgM and IgG using a lateral flow immunochromatographic assay technique. Results: Results from this study showed a total of forty-two (42) 42% subjects were reactive to IgG antibodies while fifty-eight (58) 58% subjects were non-reactive to IgG antibodies also a total of Twenty-One (21) 21% subject were reactive to IgM antibodies while a total of seventy-nine (79) 79% subjects were none reactive to IgM antibodies. A total of nine (9) subjects who were exposed to SAR-CoV-2 for more than one year were reactive to SAR-Cov-2 IgM and IgG antibodies, while a total of two (2) subjects who were exposed to SAR-CoV-2 for less than one year were reactive to SAR-Cov-2 IgM and IgG antibodies and the difference (p ₌ 0.013) was statistically significant. Also, a higher number of subjects within the 20-29 age bracket were reactive to SAR-CoV-2 IgM antibodies while subjects with in the age bracket of 30-39 were more reactive to IgG antibodies. Conclusion: This study reveals that serological testing is an ideal approach in assessing the proportion of frontline health workers who might have been exposed to SARS-CoV-2 as part of effort in combating COVID-19 disease globally.
背景:在全球范围内,一线卫生工作者与冠状病毒病(COVID-19)的斗争是一项具有挑战性的任务,他们需要在隔离中心、重症监护室、急诊科和分子实验室长时间工作,还要面对病原体、疲劳和心理困扰。这导致了全球一线卫生工作者的高发病率和高死亡率。目的:本研究旨在确定尼日利亚河流州Eleme地方政府一线卫生工作者中SARS CoV -2 IgG和IgM的分布情况。材料与方法:本研究共招募了100名一线Covid-19卫生工作者,其中男性48名,女性52名,年龄在23至49岁之间,包括在分子实验室、样本采集室和隔离中心工作的门卫、卫生员、护士、数据官、后勤和救护车司机、医生和医学实验室科学家。使用结构良好的问卷获得受试者的生物数据。只有给予知情同意的受试者才被招募参加这项研究。采用无菌技术采集每位参与者的毛细血管血液60ul,随后立即采用侧流免疫层析分析技术分析sars - cov -2 IgM和IgG。 结果:本研究结果显示,共有42(42)42%的受试者对IgG抗体有反应,58(58)58%的受试者对IgG抗体无反应,21(21)21%的受试者对IgM抗体有反应,79(79)79%的受试者对IgM抗体无反应。sars - cov -2暴露1年以上的共有9(9)名受试者对sars - cov -2 IgM和IgG抗体出现反应,暴露1年以下的共有2(2)名受试者对sars - cov -2 IgM和IgG抗体出现反应,差异有统计学意义(p值为0.013)。此外,20-29岁年龄组的受试者对sars - cov -2 IgM抗体反应性较高,而30-39岁年龄组的受试者对IgG抗体反应性较高。 结论:本研究表明,在全球抗击COVID-19疾病的努力中,血清学检测是评估可能接触过SARS-CoV-2的一线卫生工作者比例的理想方法。
{"title":"Distribution of Severe Acute Respiratory Syndrome Corona Virus-2 (SARS-CoV-2) Immunoglobulins G and M among Frontline Health Workers in Eleme Local Government of Rivers State, Nigeria","authors":"Sotonye L. Gillis-Harry, Beauty E. Echonwere-Uwikor, Evelyn M. Eze","doi":"10.9734/ibrr/2023/v14i4320","DOIUrl":"https://doi.org/10.9734/ibrr/2023/v14i4320","url":null,"abstract":"Background: The fight against Corona Virus Disease (COVID-19) globally among front line health workers has been a challenging task, it encompasses working lengthy hours at the isolation Centre’s, intensive care units, emergency departments and molecular laboratories, and also been exposed to pathogens, fatigue, and psychological distress. This has led to high morbidity and mortality rate among front line health workers all over the globe.&#x0D; Aim: This study aimed at determining the distribution of SARS CoV -2 IgG and IgM among frontline health workers in Eleme Local Government of Rivers State, Nigeria.&#x0D; Materials and Methods: A total of 100 frontline Covid-19 health workers were recruited for this study comprising 48 males and 52 females with ages between 23 and 49 years and included janitors, hygienist, nurses, data Officers, logistics and ambulance drivers, physicians, and medical laboratory scientists, working at the molecular laboratories, sample collection booths and isolation center. The bio-data of the subjects were obtained using a well-structured questionnaire. Only subjects who gave informed consent were recruited for this study. 60ul of capillary blood was collected from each participant using an aseptic technique and immediately followed by the analysis of SAR-CoV-2 IgM and IgG using a lateral flow immunochromatographic assay technique.&#x0D; Results: Results from this study showed a total of forty-two (42) 42% subjects were reactive to IgG antibodies while fifty-eight (58) 58% subjects were non-reactive to IgG antibodies also a total of Twenty-One (21) 21% subject were reactive to IgM antibodies while a total of seventy-nine (79) 79% subjects were none reactive to IgM antibodies. A total of nine (9) subjects who were exposed to SAR-CoV-2 for more than one year were reactive to SAR-Cov-2 IgM and IgG antibodies, while a total of two (2) subjects who were exposed to SAR-CoV-2 for less than one year were reactive to SAR-Cov-2 IgM and IgG antibodies and the difference (p ₌ 0.013) was statistically significant. Also, a higher number of subjects within the 20-29 age bracket were reactive to SAR-CoV-2 IgM antibodies while subjects with in the age bracket of 30-39 were more reactive to IgG antibodies.&#x0D; Conclusion: This study reveals that serological testing is an ideal approach in assessing the proportion of frontline health workers who might have been exposed to SARS-CoV-2 as part of effort in combating COVID-19 disease globally.","PeriodicalId":13659,"journal":{"name":"International Blood Research & Reviews","volume":"31 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134913363","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Umbilical Cord Blood Processing Techniques and Their Comparative Advantages: A Review 脐带血处理技术及其比较优势综述
Pub Date : 2023-09-14 DOI: 10.9734/ibrr/2023/v14i4321
Eze Evelyn Mgbeoma, Christian Serekara Gideon
Background: Umbilical Cord Blood (UCB) has steadily gained prominence in haematopoietic stem cell transplantation (HSCT). Despite UCB advantages, the main disadvantage of UCB in haematopoietic stem cell transplantation (HSCT) is its limited cell dose. Initially, UCB used to be processed and then made to undergo cryopreservation as whole cord blood banking leading to the problem of storing sufficiently large number of cryoprotected UCB units which requires vast amounts of costly storage space in liquid nitrogen. The sole purpose of processing is to concentrates the stem cells and reduce the volume for storage. Different UCB processing methods have been developed. Aim: This review is aimed at bringing together the literature on the different processing methods and highlighting the underlying principles of each method, the relative efficiency and advantages of the methods. Methodology: The work involved mainly the critical review of all available academic, professional and industry documents on cord blood processing. The relevant information was obtained from textbooks, academic journals, conference proceedings, the internet among others. The major UCB processing methods include Plasma Depletion, Density Gradient Centrifugation (DGC), Hetastarch, PrepaCyte-CB and Sepax. A study of the potential impact of Hetastarch and PrepaCyte processing methods on transplantation outcomes revealed no difference that was significant was observed between patients receiving cells after the processing regimens were compared. Results: A comparison of the engraftment time of PrepaCyte-CB with five other processing methods revealed a quicker engraftment time for PrepaCyte-CB processed cord blood units compared to other processing methods. PrepaCyte-CB also recovers significantly more viable stem cells than AutoXpress (AXP) and hydroxyethyl starch (HES) processing methods. Other workers demonstrated that Sepax depletion produces higher recovery of cells that are nucleated. The effect initial volume of cord blood had on the recovery of nucleated cells for the different method of processing were also compared. Recovery when using Sepax is reduced as the unit size processed increases. Hetastarch, which is a density gradient, and plasma depletion separation is also affected in like manner, however, processing done using PrepaCyte-CB was not affected by the initial volume of the collected unit. The advantage of Sepax is that it is fully automated and this allows for mass processing of samples, suitable for bigger cord blood banks. For erythrocyte removal, density gradient separation is a better method that is effective. PrepaCyte-CB is the second most efficient method for removing RBC. The result of Total Nucleated Cells (TNC) and Mono Nucleated Cells (MNC) recovery rate of Hespan and Sepax against AXP processing methods shows that both Hespan and Sepax reproducibly recover greater than 95% of the cord blood stem cells in a typical collection and result in
背景:脐带血(UCB)在造血干细胞移植(HSCT)中占有重要地位。尽管UCB具有优势,但UCB在造血干细胞移植(HSCT)中的主要缺点是其有限的细胞剂量。最初,脐带血通常经过处理,然后作为整个脐带血库进行冷冻保存,这导致了在液氮中储存足够数量的冷冻保护的脐带血单位的问题,这需要大量昂贵的储存空间。处理的唯一目的是浓缩干细胞,减少储存体积。不同的UCB加工方法已经被开发出来。& # x0D;目的:本文综述了不同加工方法的文献,并着重介绍了每种方法的基本原理、相对效率和优势。方法:这项工作主要涉及对所有现有的关于脐带血处理的学术、专业和行业文件进行批判性审查。相关信息来自教科书、学术期刊、会议记录、互联网等。UCB的主要处理方法包括血浆耗尽、密度梯度离心(DGC)、Hetastarch、PrepaCyte-CB和Sepax。一项关于Hetastarch和PrepaCyte处理方法对移植结果的潜在影响的研究显示,在比较处理方案后接受细胞的患者之间没有观察到显著差异。 结果:将PrepaCyte-CB与其他5种处理方法的移植时间进行比较,发现PrepaCyte-CB处理的脐带血单位的移植时间比其他处理方法更快。与autopress (AXP)和羟乙基淀粉(HES)处理方法相比,PrepaCyte-CB还能回收更多的活干细胞。其他研究人员证明,Sepax耗竭能提高有核细胞的回收率。并比较了不同处理方法下脐带血初始体积对有核细胞回收率的影响。使用Sepax时的恢复随着处理的单元大小的增加而减少。Hetastarch是一个密度梯度,血浆耗尽分离也以类似的方式受到影响,然而,使用PrepaCyte-CB进行的处理不受收集单元的初始体积的影响。Sepax的优势在于它是全自动的,这允许大量处理样本,适用于较大的脐带血库。对于红细胞的去除,密度梯度分离是一种较好的、有效的方法。PrepaCyte-CB是去除RBC的第二有效方法。Hespan和Sepax对AXP处理方法的总有核细胞(TNC)和单有核细胞(MNC)回收率结果表明,Hespan和Sepax在典型标本中可重复性地回收95%以上的脐带血干细胞,并减少最终储存的最终体积。 结论:血浆衰竭、密度梯度、Hetastarch、PrepaCyte-CB和自动离心机(Sepax)是最常用的5种处理技术。大多数方法包括离心、沉淀和/或过滤,以减少红细胞含量、血浆体积,或两者兼而有之。不同的UCB处理方法各有其优点和缺点。
{"title":"Umbilical Cord Blood Processing Techniques and Their Comparative Advantages: A Review","authors":"Eze Evelyn Mgbeoma, Christian Serekara Gideon","doi":"10.9734/ibrr/2023/v14i4321","DOIUrl":"https://doi.org/10.9734/ibrr/2023/v14i4321","url":null,"abstract":"Background: Umbilical Cord Blood (UCB) has steadily gained prominence in haematopoietic stem cell transplantation (HSCT). Despite UCB advantages, the main disadvantage of UCB in haematopoietic stem cell transplantation (HSCT) is its limited cell dose. Initially, UCB used to be processed and then made to undergo cryopreservation as whole cord blood banking leading to the problem of storing sufficiently large number of cryoprotected UCB units which requires vast amounts of costly storage space in liquid nitrogen. The sole purpose of processing is to concentrates the stem cells and reduce the volume for storage. Different UCB processing methods have been developed. &#x0D; Aim: This review is aimed at bringing together the literature on the different processing methods and highlighting the underlying principles of each method, the relative efficiency and advantages of the methods.&#x0D; Methodology: The work involved mainly the critical review of all available academic, professional and industry documents on cord blood processing. The relevant information was obtained from textbooks, academic journals, conference proceedings, the internet among others. The major UCB processing methods include Plasma Depletion, Density Gradient Centrifugation (DGC), Hetastarch, PrepaCyte-CB and Sepax. A study of the potential impact of Hetastarch and PrepaCyte processing methods on transplantation outcomes revealed no difference that was significant was observed between patients receiving cells after the processing regimens were compared.&#x0D; Results: A comparison of the engraftment time of PrepaCyte-CB with five other processing methods revealed a quicker engraftment time for PrepaCyte-CB processed cord blood units compared to other processing methods. PrepaCyte-CB also recovers significantly more viable stem cells than AutoXpress (AXP) and hydroxyethyl starch (HES) processing methods. Other workers demonstrated that Sepax depletion produces higher recovery of cells that are nucleated. The effect initial volume of cord blood had on the recovery of nucleated cells for the different method of processing were also compared. Recovery when using Sepax is reduced as the unit size processed increases. Hetastarch, which is a density gradient, and plasma depletion separation is also affected in like manner, however, processing done using PrepaCyte-CB was not affected by the initial volume of the collected unit. The advantage of Sepax is that it is fully automated and this allows for mass processing of samples, suitable for bigger cord blood banks. For erythrocyte removal, density gradient separation is a better method that is effective. PrepaCyte-CB is the second most efficient method for removing RBC. The result of Total Nucleated Cells (TNC) and Mono Nucleated Cells (MNC) recovery rate of Hespan and Sepax against AXP processing methods shows that both Hespan and Sepax reproducibly recover greater than 95% of the cord blood stem cells in a typical collection and result in ","PeriodicalId":13659,"journal":{"name":"International Blood Research & Reviews","volume":"29 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134913722","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What a Clinical Hematologist should Know about B Cells? 关于B细胞,临床血液学家应该知道些什么?
Pub Date : 2022-01-10 DOI: 10.9734/ibrr/2022/v13i130166
S. Sharma
B cells are very crucial part of our immune system. They protect us from various infections by secreting antigen-specific antibodies, which neutralize the infectious agents. It is important for a clinical hematologist to know about the B cell development, function and the diseases developing from the quantitative or qualitative defects in B cells. This simple and short review is focused on the basic understanding and clinical hematologist’s perspective of B cells.
B细胞是我们免疫系统的重要组成部分。它们通过分泌抗原特异性抗体来保护我们免受各种感染,这种抗体可以中和感染因子。从B细胞的定量或定性缺陷中了解B细胞的发育、功能和疾病的发生,对临床血液学工作者具有重要意义。这篇简单而简短的综述主要是对B细胞的基本认识和临床血液学家的观点。
{"title":"What a Clinical Hematologist should Know about B Cells?","authors":"S. Sharma","doi":"10.9734/ibrr/2022/v13i130166","DOIUrl":"https://doi.org/10.9734/ibrr/2022/v13i130166","url":null,"abstract":"B cells are very crucial part of our immune system. They protect us from various infections by secreting antigen-specific antibodies, which neutralize the infectious agents. It is important for a clinical hematologist to know about the B cell development, function and the diseases developing from the quantitative or qualitative defects in B cells. This simple and short review is focused on the basic understanding and clinical hematologist’s perspective of B cells.","PeriodicalId":13659,"journal":{"name":"International Blood Research & Reviews","volume":"12 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73580943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of Coagulation and Haematological Parameters among Pregnant Women in Port Harcourt 哈科特港孕妇凝血和血液学指标的评估
Pub Date : 2022-01-05 DOI: 10.9734/ibrr/2022/v13i130165
B. Echonwere-uwikor, F. K. Uwikor, O. Chukuigwe-Igbere, P. H. Chukwu, Gift Worlu
Background: Pregnancy is the fertilization and development of an embryo or fetus in a woman's uterus. It is a critical stage of development during which maternal nutrition can strongly influence obstetric and neonatal outcomes. The aim of this study was to determine the effect of pregnancy on some coagulation and haematological parameters of pregnant women residing in Port Harcourt, Nigeria. Method: This case-control study investigated 80 pregnant subjects and 20 non-pregnant controls. Haematological parameters were determined using a fully automated The SysmexXP-300, while the coagulation parameters (PT and INR) were determined with the automated method. Results: The mean PT (s), HB (g/dl), PCV (%), PLT (x109/L), RBC (mcL), LYMPH (%), BASO (%) and EOSIN (%) counts were significantly lower among the pregnant subjects (5.02±5.82, 11.00±1.13 g/dl and 33.81±3.89%, 189.6±52.93 × 109/L, 3.95±0.50, 43.93±10.10 %, 0.9385±1.08 % and 1.12±1.32 %) compared to the non-pregnant controls (1.68±2.37, 12.01±1.29 g/dl, 37.31±3.39 %, 235.6±72.37 × 109/L, 4.45±0.35, 43.24±9.06, 2.11±0.94 and 2.15±1.47) respectively. There were no significant differences in the INR, MONO (%), MPV (fl), MCV (L/C), and MCH (g/c) between the pregnant subjects (0.92±0.11, 5.41±2.59 %, 11.67±4.848, 84.26±3.77 and 28.06±3.54) and non-pregnant controls (0.88±0.11, 5.58±2.65, 11.14±5.45, 82.52±10.45 and 26.96±1.85). The NEUT (%), PDW (%) and WBC (x109/L) were significantly higher among the pregnant subjects (44.90±11.24 %, 13.26±2.56 % and 8.35±2.982 x109/L) compared to the non-pregnant controls (46.63±9.96 %, 10.78±1.80 % and 4.71±0.81 x109/L). Conclusion: This study has shown that pregnancy has a significant effect on some haematological and coagulation parameters of pregnant women in Port Harcourt. The result of this research work indicates the need to routinely monitor the complete blood count, thrombocytopenia and hyper-coagulative activity among pregnant women of African descendant.
背景:怀孕是胚胎或胎儿在女性子宫内受精和发育的过程。这是发育的一个关键阶段,在此期间,产妇营养对产科和新生儿结局有很大影响。本研究的目的是确定怀孕对居住在尼日利亚哈科特港的孕妇的一些凝血和血液学参数的影响。方法:采用病例-对照研究,对80例孕妇和20例非孕妇进行调查。血液学参数采用全自动SysmexXP-300测定,凝血参数(PT和INR)采用自动化方法测定。结果:妊娠组PT (s)、HB (g/dl)、PCV(%)、PLT (x109/L)、RBC (mcL)、LYMPH(%)、BASO(%)、EOSIN(%)的平均值分别为5.02±5.82、11.00±1.13 g/dl和33.81±3.89%、189.6±52.93 × 109/L、3.95±0.50、43.93±10.10%、0.9385±1.08%和1.12±1.32%,显著低于未妊娠组(1.68±2.37、12.01±1.29 g/dl、37.31±3.39%、235.6±72.37 × 109/L、4.45±0.35、43.24±9.06、2.11±0.94和2.15±1.47)。妊娠组的INR、MONO(%)、MPV (fl)、MCV (L/C)、MCH (g/ C)在妊娠组(0.92±0.11、5.41±2.59 %、11.67±4.848、84.26±3.77、28.06±3.54)与未妊娠组(0.88±0.11、5.58±2.65、11.14±5.45、82.52±10.45、26.96±1.85)之间无显著差异。妊娠组NEUT(%)、PDW(%)和WBC (x109/L)分别为44.90±11.24%、13.26±2.56%和8.35±2.982 x109/L,显著高于未妊娠组(46.63±9.96%、10.78±1.80%和4.71±0.81 x109/L)。结论:本研究表明,妊娠对哈科特港孕妇的一些血液学和凝血参数有显著影响。本研究结果提示非洲裔孕妇需要常规监测全血细胞计数、血小板减少症和高凝血活性。
{"title":"Assessment of Coagulation and Haematological Parameters among Pregnant Women in Port Harcourt","authors":"B. Echonwere-uwikor, F. K. Uwikor, O. Chukuigwe-Igbere, P. H. Chukwu, Gift Worlu","doi":"10.9734/ibrr/2022/v13i130165","DOIUrl":"https://doi.org/10.9734/ibrr/2022/v13i130165","url":null,"abstract":"Background: Pregnancy is the fertilization and development of an embryo or fetus in a woman's uterus. It is a critical stage of development during which maternal nutrition can strongly influence obstetric and neonatal outcomes. The aim of this study was to determine the effect of pregnancy on some coagulation and haematological parameters of pregnant women residing in Port Harcourt, Nigeria. \u0000Method: This case-control study investigated 80 pregnant subjects and 20 non-pregnant controls. Haematological parameters were determined using a fully automated The SysmexXP-300, while the coagulation parameters (PT and INR) were determined with the automated method. \u0000Results: The mean PT (s), HB (g/dl), PCV (%), PLT (x109/L), RBC (mcL), LYMPH (%), BASO (%) and EOSIN (%) counts were significantly lower among the pregnant subjects (5.02±5.82, 11.00±1.13 g/dl and 33.81±3.89%, 189.6±52.93 × 109/L, 3.95±0.50, 43.93±10.10 %, 0.9385±1.08 % and 1.12±1.32 %) compared to the non-pregnant controls (1.68±2.37, 12.01±1.29 g/dl, 37.31±3.39 %, 235.6±72.37 × 109/L, 4.45±0.35, 43.24±9.06, 2.11±0.94 and 2.15±1.47) respectively. There were no significant differences in the INR, MONO (%), MPV (fl), MCV (L/C), and MCH (g/c) between the pregnant subjects (0.92±0.11, 5.41±2.59 %, 11.67±4.848, 84.26±3.77 and 28.06±3.54) and non-pregnant controls (0.88±0.11, 5.58±2.65, 11.14±5.45, 82.52±10.45 and 26.96±1.85). The NEUT (%), PDW (%) and WBC (x109/L) were significantly higher among the pregnant subjects (44.90±11.24 %, 13.26±2.56 % and 8.35±2.982 x109/L) compared to the non-pregnant controls (46.63±9.96 %, 10.78±1.80 % and 4.71±0.81 x109/L). \u0000Conclusion: This study has shown that pregnancy has a significant effect on some haematological and coagulation parameters of pregnant women in Port Harcourt. The result of this research work indicates the need to routinely monitor the complete blood count, thrombocytopenia and hyper-coagulative activity among pregnant women of African descendant.","PeriodicalId":13659,"journal":{"name":"International Blood Research & Reviews","volume":"11 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84756803","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of Some Haematological, Coagulation and Immune Parameters among Male Oil Refinery Workers in Port Harcourt, Nigeria 尼日利亚哈科特港男性炼油厂工人血液学、凝血和免疫指标的评估
Pub Date : 2021-12-03 DOI: 10.9734/ibrr/2021/v13i130164
Ehiaghe-Shepherd, Bridget Obofoni, Christian, Serekara Gideon, Eze, Evelyn Mgbeoma
Aim: The aim of this study was to assess the levels of some hematological, coagulation and immune parameters among male oil refinery workers in Port Harcourt, Nigeria. Study Design: This study is a cross-sectional study. Place and Duration of Study: Rivers State University Teaching Hospital (RSUTH), Port Harcourt, Shell Petroleum Development Company of Nigeria Limited and Modular Oil Refinery, Rivers State, between January 2021 and September 2021. Methodology: A total of one hundred (100) subjects (50 oil and gas workers as test subjects and 50 non-oil and gas workers as control subjects), were enrolled in the study. The convenient sampling technique was employed in the study. Venous blood samples were collected from all subjects and tested for Prothrombin Time (PT), Activated Partial Thromboplastin Time (APTT), Fibrinogen concentration, Full Blood Count (FBC) (Haemoglobin (Hb), Packed Cell Volume (PCV), Total White Blood Cell (WBC) count, Lymphocyte, Neutrophils, monocytes and Platelet Count), CD4 cell count, CD3 cell count and CD8 cell count. Data generated were analyzed statistically using Graph-Pad Prism, Version 8.0.2. Results: There was statistically significant decrease (P<.001) in Prothrombin time (PT) (11.55±0.73s), International Normalized Ratio (INR) (0.85±0.05), Fibrinogen (202.4±27.4mg/dl), Platelet count (185.6±37.1(103/μl)) and Neutrophils (46.6±6.4%) in oil refinery workers exposed to gas flare, while there was a statistical significant increase in APTT (31.8±4.15s), Hb (13.7±1.0g/dl), PCV (41.1±3.2%), Monocytes (8.4±3.0%) in subjects exposed to gas flare over control subjects with Prothrombin time(12.23±0.82s), INR(0.90±0.06), Fibrinogen(252.0±57.0mg/dl), platelet count(213.3±49.5(103/μl)) and Neutrophils(52.6±11.7%). Other parameters showed no statistical significant difference at P<.05 in both test and control subjects. Comparison of the mean ± standard deviation of the studied parameters in test subjects based on age using Analysis of Variance showed no statistically significant difference in all parameters at P<.05. Also, Comparison of the mean ± standard deviation of the studied parameters in test subjects based on duration of Exposure using Analysis of Variance showed a significant decrease in CD8 cells as the years of exposure increase (2-5years exposure = 865±319, 6-10years exposure = 579±288, 11-20 years exposure = 591± 286, F- Value = 3.869, P- Value = 0.0278). Conclusion: In conclusion, based on the findings, some haematogical, coagulation and immune parameters increased while others decreased in male oil refinery workers and duration of exposure can also be considered as a risk factor and age was considered not a risk factor as to cause any aberrations in the studied parameters.
目的:本研究的目的是评估尼日利亚哈科特港男性炼油厂工人的一些血液学、凝血和免疫参数的水平。研究设计:本研究为横断面研究。学习地点和时间:2021年1月至2021年9月,河流州立大学教学医院(RSUTH),哈科特港,尼日利亚壳牌石油开发公司有限公司和河流州立模块化炼油厂。方法:共纳入100名受试者(50名油气工人为测试对象,50名非油气工人为对照对象)。本研究采用方便抽样技术。采集所有受试者静脉血,检测凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、纤维蛋白原浓度、全血细胞计数(FBC)(血红蛋白(Hb)、堆积细胞体积(PCV)、白细胞总数(WBC)、淋巴细胞、中性粒细胞、单核细胞和血小板计数)、CD4细胞计数、CD3细胞计数和CD8细胞计数。生成的数据使用Graph-Pad Prism, Version 8.0.2进行统计分析。结果:炼油厂工人接触天然气火炬后凝血酶原时间(PT)(11.55±0.73s)、国际标准化比值(INR)(0.85±0.05)、纤维蛋白原(202.4±27.4mg/dl)、血小板计数(185.6±37.1(103/μl))、中性粒细胞(46.6±6.4%)下降有统计学意义(P< 0.001), APTT(31.8±4.15s)、Hb(13.7±1.0g/dl)、PCV(41.1±3.2%)、在凝血酶原时间(12.23±0.82s)、INR(0.90±0.06)、纤维蛋白原(252.0±57.0mg/dl)、血小板计数(213.3±49.5(103/μl))和中性粒细胞(52.6±11.7%)方面,气体火炬暴露组的单核细胞(8.4±3.0%)高于对照组。其他参数差异无统计学意义(P<)。实验组和对照组均为0.05。用方差分析比较被试年龄的研究参数的均数±标准差,各参数差异无统计学意义,P< 0.05。采用方差分析方法比较暴露时间对被试各项参数的均值±标准差,发现CD8细胞随着暴露时间的增加而显著降低(2-5年暴露= 865±319,6-10年暴露= 579±288,11-20年暴露= 591±286,F值= 3.869,P值= 0.0278)。结论:综上所述,男性炼油工人的血液学、凝血学和免疫指标有些升高,有些降低,暴露时间也可能是导致研究参数畸变的危险因素,而年龄不是导致畸变的危险因素。
{"title":"Assessment of Some Haematological, Coagulation and Immune Parameters among Male Oil Refinery Workers in Port Harcourt, Nigeria","authors":"Ehiaghe-Shepherd, Bridget Obofoni, Christian, Serekara Gideon, Eze, Evelyn Mgbeoma","doi":"10.9734/ibrr/2021/v13i130164","DOIUrl":"https://doi.org/10.9734/ibrr/2021/v13i130164","url":null,"abstract":"Aim: The aim of this study was to assess the levels of some hematological, coagulation and immune parameters among male oil refinery workers in Port Harcourt, Nigeria. \u0000Study Design: This study is a cross-sectional study. \u0000Place and Duration of Study: Rivers State University Teaching Hospital (RSUTH), Port Harcourt, Shell Petroleum Development Company of Nigeria Limited and Modular Oil Refinery, Rivers State, between January 2021 and September 2021. \u0000Methodology: A total of one hundred (100) subjects (50 oil and gas workers as test subjects and 50 non-oil and gas workers as control subjects), were enrolled in the study. The convenient sampling technique was employed in the study. Venous blood samples were collected from all subjects and tested for Prothrombin Time (PT), Activated Partial Thromboplastin Time (APTT), Fibrinogen concentration, Full Blood Count (FBC) (Haemoglobin (Hb), Packed Cell Volume (PCV), Total White Blood Cell (WBC) count, Lymphocyte, Neutrophils, monocytes and Platelet Count), CD4 cell count, CD3 cell count and CD8 cell count. Data generated were analyzed statistically using Graph-Pad Prism, Version 8.0.2. \u0000Results: There was statistically significant decrease (P<.001) in Prothrombin time (PT) (11.55±0.73s), International Normalized Ratio (INR) (0.85±0.05), Fibrinogen (202.4±27.4mg/dl), Platelet count (185.6±37.1(103/μl)) and Neutrophils (46.6±6.4%) in oil refinery workers exposed to gas flare, while there was a statistical significant increase in APTT (31.8±4.15s), Hb (13.7±1.0g/dl), PCV (41.1±3.2%), Monocytes (8.4±3.0%) in subjects exposed to gas flare over control subjects with Prothrombin time(12.23±0.82s), INR(0.90±0.06), Fibrinogen(252.0±57.0mg/dl), platelet count(213.3±49.5(103/μl)) and Neutrophils(52.6±11.7%). Other parameters showed no statistical significant difference at P<.05 in both test and control subjects. Comparison of the mean ± standard deviation of the studied parameters in test subjects based on age using Analysis of Variance showed no statistically significant difference in all parameters at P<.05. Also, Comparison of the mean ± standard deviation of the studied parameters in test subjects based on duration of Exposure using Analysis of Variance showed a significant decrease in CD8 cells as the years of exposure increase (2-5years exposure = 865±319, 6-10years exposure = 579±288, 11-20 years exposure = 591± 286, F- Value = 3.869, P- Value = 0.0278). \u0000Conclusion: In conclusion, based on the findings, some haematogical, coagulation and immune parameters increased while others decreased in male oil refinery workers and duration of exposure can also be considered as a risk factor and age was considered not a risk factor as to cause any aberrations in the studied parameters.","PeriodicalId":13659,"journal":{"name":"International Blood Research & Reviews","volume":"52 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82125768","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigation of FMS-Like Tyrosine Kinase 3 Mutation Frequency in Myelodysplastic Syndrome 骨髓增生异常综合征中fms样酪氨酸激酶3突变频率的研究
Pub Date : 2021-11-02 DOI: 10.9734/ibrr/2021/v13i130163
Nesim Akın, A. Turgutkaya, S. I. Yavaşoğlu, Esra Örenlili Yaylagül, Celal Ülger, A. Bolaman, I. Yavaşoğlu
Introduction: FMS-Like Tyrosine Kinase Class 3 (FLT3) mutations harbor poor prognosis, high relapse, and decreased overall survival in acute myeloblastic leukemia (AML). This mutation is also known to be demonstrated in myelodysplastic syndrome (MDS), chronic myelomonocytic leukemia and acute lymphoblastic leukemia. This study included 94 MDS-diagnosed patients and we tried to investigate FLT3 mutation frequency (as tyrosine kinase domain-TKD and internal tandem duplication-ITD). Materials and Methods: Polymerase chain reaction (PCR), restriction fragment length polymorphism, and agarose-gel electrophoresis methods were used to analyze the mutation. The blood samples were collected in K3-EDTA tubes, and total DNA was isolated using genomic DNA isolation kits (GeneMark, Cat No: DP023P). For the detection of FLT3-ITD mutation, PCR was performed to amplify a 330- base pair fragment of exons 11 and 12 of FLT3 using FAM (Carboxyfluorescein)-labeled ITD-11F and HEX (Hexachloro-Fluorescein )-labeled  ITD-12R primers in a thermal cycler (Eppendorf). Similarly, to detect D835 mutation, a 115- bp region of exon 17 of the FLT3 gene region was amplified using primers. Results: One patient was found FLT3-ITD positive (1.1%). The patient was 64-year-old and diagnosed with MDS-excess blast type 2 according to the World Health Organisation 2016 myeloid neoplasm classification. He transformed to AML within 19 months and subsequently died after 1 month. No patient with tyrosine kinase domain mutation was detected. Conclusion: FLT3 mutation is considered a significant parameter to define prognosis in AML. The routine workup of FLT3 screening and the potential of targeting FLT3 inhibition for high-risk MDS may be taken into consideration in the future.
简介:fms样酪氨酸激酶3类(FLT3)突变在急性髓母细胞白血病(AML)中预后差,复发率高,总生存率降低。这种突变也被证明在骨髓增生异常综合征(MDS),慢性髓细胞白血病和急性淋巴细胞白血病。本研究纳入94例mds诊断患者,我们试图调查FLT3突变频率(酪氨酸激酶结构域tkd和内部串联重复itd)。材料与方法:采用聚合酶链反应(PCR)、限制性内切片段长度多态性、琼脂糖凝胶电泳等方法对突变株进行分析。采用K3-EDTA管采集血样,采用基因组DNA分离试剂盒(GeneMark, Cat No: DP023P)分离总DNA。为了检测FLT3- itd突变,使用FAM (Carboxyfluorescein)标记的ITD-11F和HEX (Hexachloro-Fluorescein)标记的ITD-12R引物在热循环器(Eppendorf)中扩增FLT3外显子11和12的330碱基对片段。同样,为了检测D835突变,使用引物扩增FLT3基因区域外显子17的115- bp区域。结果:1例患者FLT3-ITD阳性(1.1%)。患者64岁,根据世界卫生组织2016年髓系肿瘤分类,被诊断为mds -过量blast 2型。他在19个月内转化为AML,随后在1个月后死亡。未发现酪氨酸激酶结构域突变患者。结论:FLT3突变被认为是确定AML预后的重要参数。FLT3筛查的常规检查和靶向FLT3抑制高风险MDS的潜力可能在未来被考虑。
{"title":"Investigation of FMS-Like Tyrosine Kinase 3 Mutation Frequency in Myelodysplastic Syndrome","authors":"Nesim Akın, A. Turgutkaya, S. I. Yavaşoğlu, Esra Örenlili Yaylagül, Celal Ülger, A. Bolaman, I. Yavaşoğlu","doi":"10.9734/ibrr/2021/v13i130163","DOIUrl":"https://doi.org/10.9734/ibrr/2021/v13i130163","url":null,"abstract":"Introduction: FMS-Like Tyrosine Kinase Class 3 (FLT3) mutations harbor poor prognosis, high relapse, and decreased overall survival in acute myeloblastic leukemia (AML). This mutation is also known to be demonstrated in myelodysplastic syndrome (MDS), chronic myelomonocytic leukemia and acute lymphoblastic leukemia. This study included 94 MDS-diagnosed patients and we tried to investigate FLT3 mutation frequency (as tyrosine kinase domain-TKD and internal tandem duplication-ITD). \u0000Materials and Methods: Polymerase chain reaction (PCR), restriction fragment length polymorphism, and agarose-gel electrophoresis methods were used to analyze the mutation. The blood samples were collected in K3-EDTA tubes, and total DNA was isolated using genomic DNA isolation kits (GeneMark, Cat No: DP023P). For the detection of FLT3-ITD mutation, PCR was performed to amplify a 330- base pair fragment of exons 11 and 12 of FLT3 using FAM (Carboxyfluorescein)-labeled ITD-11F and HEX (Hexachloro-Fluorescein )-labeled  ITD-12R primers in a thermal cycler (Eppendorf). Similarly, to detect D835 mutation, a 115- bp region of exon 17 of the FLT3 gene region was amplified using primers. \u0000Results: One patient was found FLT3-ITD positive (1.1%). The patient was 64-year-old and diagnosed with MDS-excess blast type 2 according to the World Health Organisation 2016 myeloid neoplasm classification. He transformed to AML within 19 months and subsequently died after 1 month. No patient with tyrosine kinase domain mutation was detected. \u0000Conclusion: FLT3 mutation is considered a significant parameter to define prognosis in AML. The routine workup of FLT3 screening and the potential of targeting FLT3 inhibition for high-risk MDS may be taken into consideration in the future.","PeriodicalId":13659,"journal":{"name":"International Blood Research & Reviews","volume":"94 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83911963","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International Blood Research & Reviews
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1